Resmed Inc. buy JPMorgan Chase & Co.
Start price
24.04.25
/
50%
€208.50
Target price
24.04.26
€255.40
Performance (%)
4.32%
Price
15:13
€217.50
Summary
This prediction is currently active. With a performance of 4.32%, the BUY prediction by JPMorgan_Chase___Co_ for Resmed Inc. is trending in the right direction. This prediction currently runs until 24.04.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.528% | -2.528% |
| iShares Core DAX® | 0,19 % | -1,22 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % |
| iShares S&P 500 | -1,01 % | -3,40 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat